Drug Shortage Prevention Act of 2025 aims to enhance notification procedures for critical drug shortages.
The Drug Shortage Prevention Act of 2025 amends the Federal Food, Drug, and Cosmetic Act to improve notification procedures for critical drug shortages. It requires manufacturers to notify the Secretary of Health and Human Services about potential shortages, including permanent discontinuances, interruptions, or other circumstances that may lead to a meaningful disruption in supply. Notifications must include details such as the reasons for the disruption, the expected duration, and any relevant information about active pharmaceutical ingredients.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.